Drug Delivery Systems for the Treatment of Oral Cavity Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 20 May 2025
Special Issue Editor
2. Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
Interests: cell–material interactions; drug delivery; biological characterization of nano- and micromaterials
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diseases affecting the oral cavity—such as periodontal diseases, infections, mucosal lesions, and conditions associated with chronic diseases like diabetes—often require targeted, localized treatments. Recent advancements in drug delivery systems for the oral cavity offer innovative solutions for enhancing therapeutic efficacy, minimizing side effects, and improving patient compliance. These systems include advanced topical formulations, nanoparticles, adhesive gels, extended-release systems, oral patches, and microdevices designed to deliver drugs in a controlled and optimized manner.
The goal of this Special Issue is to gather recent studies and innovative research on drug delivery systems for targeted oral treatments. We welcome contributions on new technologies, preclinical and clinical studies, as well as in vitro and in vivo evaluations of these delivery systems. Special emphasis will be given to biocompatible materials, extended-release methodologies, and their application in patients with specific oral conditions.
Dr. Giuseppina Nocca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- targeted drug delivery
- oral cavity diseases
- biocompatible materials
- extended-release systems
- nanoparticles and microdevices
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
